Ling Jie Wang
About
Ling Jie Wang has authored 16 papers that have received a total of 523 indexed citations.
This includes 7 papers in Clinical Biochemistry, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. The topics of these papers are Advanced Glycation End Products research (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Ling Jie Wang is often cited by papers focused on Advanced Glycation End Products research (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Peroxisome Proliferator-Activated Receptors (2 papers) and collaborates with scholars based in China and Italy. Ling Jie Wang's co-authors include Wei Feng Shen, Lin Lu, Ruiyan Zhang, Qiujing Chen and Xiao Xiang Yan and has published in prestigious journals such as Journal of the American College of Cardiology, Arteriosclerosis Thrombosis and Vascular Biology and European Heart Journal.
In The Last Decade
Explore authors with similar magnitude of impact
Top authors papers by Josep M. González are co-authored with Top journals papers by Jianping Li are published in Top countries impacted by papers by Sharad C. Karad Top authors papers by Daria Vay are co-authored with Top authors papers by Jean‐Pierre Dufaure are co-authored with Top countries impacted by papers by Jean Sébastien Guillamo Top authors papers by Qidi Wang are co-authored with Top journals papers by Kathleen Wheatley are published in